Leadership Group for a Clinical Research Network on Antibacterial Resistance Program

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise referred to as NIH, is an agency operating within the United States Department of Health and Human Services that's primarily accountable for ensuring and financially supporting the country's biomedical and health-related research studies.

The grants and initiatives of the NIH are all designed to contribute to the realization of its general agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program wherein both agencies tend to support the common goal of seeking applications from domestic institutions/organizations expressing their intent to serve as the Leadership Group for a Clinical Research Network on Antibacterial Resistance.

The primary purpose of this inquiry is to create, prioritize, implement, and manage and integrated clinical research program that could potentially lead to the alleviation of antibacterial resistance.

  (continued...)

Leadership Group for a Clinical Research Network on Antibacterial Resistance Program
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on philanthropy giving and community grants.

Additional Resources

category - Health Grants

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---

Behavioral Risk Factor Surveillance System
The Centers for Disease Control and Prevention has established the Behavioral Risk Factor Surveillance System Program wherein it intends to provide financial and programmatic assistance to State Health Departments in the process of maintaining and expanding ways of collecting pertinent health data.

---

Developing and Strengthening Services and Systems that Support Family Cohesion and Respond to the Separation of Children in Democratic Republic of Congo
USAID-DRC has established a program entitled Developing and Strengthening Services and Systems that Support Family Cohesion and Respond to the Separation of Children in Democratic Republic of Congo.

---